ReviewJournal of clinical pharmacology2025

A Systematic Evaluation of the Dosing Regimens for Approved Targeted Therapies and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma From a Project OPTIMUS Perspective.

Zhiyuan Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.